Lactobacillus paracasei – LPC09 (DSM 24243)

Overview

Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence

Scientific reference(s)

Clinical studies on-going on LP01+LPC09+Bb1 and other actives in prostate health

Mogna L. et al. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans? (LPC09, LA02, LP01, LRE02, BR03, BL03) J Clin Gastroenterol. 2014; 48 Suppl:S91-95.

+ Internal data on anti-inflammatory and anti-oxidant properties available upon request on certain strains

Additional info

Therapeutical area(s)

Urogenital system

Functionality

Kidney stones

Age/Gender

Adults

Search strain on Pubmed

MicrobiomeHUB is a space that brings together the companies of the microbiome industry

Brought to you by Clorofilla Scientific Publishing

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomeHUB’s Privacy Policy